Found: 9
Select item for more details and to access through your institution.
Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 49, doi. 10.1007/s40256-016-0195-y
- By:
- Publication type:
- Article
Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 61, doi. 10.1007/s40256-016-0196-x
- By:
- Publication type:
- Article
Erratum to: Optimizing the Use of Cangrelor in the Real World.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 81, doi. 10.1007/s40256-016-0201-4
- By:
- Publication type:
- Article
Optimizing the Use of Cangrelor in the Real World.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 5, doi. 10.1007/s40256-016-0192-1
- By:
- Publication type:
- Article
Recent Perioperative Pharmacological Prevention of Acute Kidney Injury after Cardiac Surgery: A Narrative Review.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 17, doi. 10.1007/s40256-016-0194-z
- By:
- Publication type:
- Article
A Review of the Efficacy, Safety, and Clinical Implications of Naturally Derived Dietary Supplements for Dyslipidemia.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 27, doi. 10.1007/s40256-016-0191-2
- By:
- Publication type:
- Article
Acknowledgement to Referees.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 1, doi. 10.1007/s40256-016-0207-y
- Publication type:
- Article
Selexipag: A Review in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 73, doi. 10.1007/s40256-016-0209-9
- By:
- Publication type:
- Article
Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data.
- Published in:
- American Journal of Cardiovascular Drugs, 2017, v. 17, n. 1, p. 37, doi. 10.1007/s40256-016-0189-9
- By:
- Publication type:
- Article